Table 3.
Baseline characteristics of the subjects divided by individuals with or without central obesity and metabolic syndrome
| Without central obesity, without MetS | With central obesity, without MetS | Without central obesity, with MetS | With central obesity, with MetS | |
|---|---|---|---|---|
| Men/Women | 187/283 | 78/112 | 65/77 | 49/77 |
| Age (years) | 59.6 ± 14.5 | 60.2 ± 13.7 | 63.6 ± 11.5* | 62.8 ± 10.3* |
| Body mass index (kg/m2) | 21.9 ± 2.8 | 26.2 ± 3.4* | 22.9 ± 2.6* | 26.9 ± 3.3* |
| Waist circumference (cm) | 74.2 ± 7.8 | 84.7 ± 9.4* | 77.4 ± 7.2* | 86.3 ± 8.8* |
| Systolic blood pressure (mmHg) | 128.4 ± 17.0 | 132.2 ± 16.3* | 139.0 ± 17.4* | 134.8 ± 12.7* |
| Diastolic blood pressure (mmHg) | 72.6 ± 10.1 | 74.5 ± 10.1* | 78.3 ± 10.3* | 76.8 ± 9.8* |
| Fasting glucose (mg/dL) | 85.7 ± 9.9 | 88.2 ± 10.8* | 90.9 ± 11.0* | 93.3 ± 10.4* |
| 2-h glucose (mg/dL) | 105.1 ± 30.4 | 114.2 ± 29.7* | 126.1 ± 32.8* | 129.4 ± 31.7* |
| Fasting insulin (μU/mL)† | 5.9 ± 3.1 | 9.0 ± 5.8* | 7.9 ± 4.6* | 11.1 ± 7.5* |
| 2-h insulin (μU/mL)† | 47.1 ± 36.4 | 68.2 ± 58.7* | 64.2 ± 39.2* | 88.8 ± 71.9* |
| HOMA-IR† | 1.3 ± 0.8 | 2.0 ± 1.4* | 1.8 ± 1.2* | 2.6 ± 1.9* |
| Total cholesterol (mg/dL) | 220.3 ± 37.3 | 223.6 ± 35.4 | 229.1 ± 35.2* | 230.6 ± 39.7* |
| Triglycerides (mg/dL)† | 123.8 ± 86.1 | 157.7 ± 160.7* | 226.4 ± 172.5* | 209.5 ± 146.3* |
| HDL cholesterol (mg/dL) | 56.6 ± 14.2 | 51.2 ± 12.5* | 46.8 ± 15.3* | 47.2 ± 15.7* |
| Impaired glucose tolerance (%) | 68 (14.5) | 38 (20.0) | 55 (38.7)* | 48 (38.1)* |
| Developed to diabetes (%) | 32 (6.8) | 14 (7.4) | 33 (23.2)* | 37 (29.4)* |
Data are expressed as means ± SD. P values are determined by unpaired t-test or χ2 test.
†
Parameters are transformed logarithmically before analysis. MetS, metabolic syndrome; HOMA-IR, homeostasis model assessment of insulin resistance; HDL, high density lipoprotein.
*
P < 0.05 compared to by individuals without central obesity and without MetS.